Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BLACKROCK INC BLK | 1,673,483 7.800% | -261,228 (-13.50%) | Filing History |
| 2025-02-14 5:05 pm Purchase | 2025-02-12 | 13D | Enanta Pharmaceuticals, Inc. ENTA | Luly Jay R. | 1,703,616 7.700% | 337,298 (+24.69%) | Filing History |
| 2025-02-11 12:11 pm Purchase | 2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL PARTNERS LP | 2,108,262 9.900% | 83,262 (+4.11%) | Filing History |
| 2025-01-22 4:01 pm Purchase | 2025-01-14 | 13G | Enanta Pharmaceuticals, Inc. ENTA | INTEGRATED CORE STRATEGIES (US) LLC | 1,382,273 6.500% | 1,382,273 (New Position) | Filing History |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 1,000,000 4.720% | -1,064,000 (-51.55%) | Filing History |
| 2024-10-17 4:31 pm Sale | 2024-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | MILLENNIUM MANAGEMENT L.L.C. | 731,295 3.500% | -583,654 (-44.39%) | Filing History |
| 2024-02-27 1:11 pm Purchase | 2024-02-22 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Krensavage Asset Management LLC | 1,086,024 5.100% | 1,086,024 (New Position) | Filing History |
| 2024-02-14 2:26 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 2,064,000 9.800% | -14,000 (-0.67%) | Filing History |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Enanta Pharmaceuticals, Inc. ENTA | VANGUARD GROUP INC | 1,793,786 8.520% | 271,597 (+17.84%) | Filing History |
| 2024-01-26 09:11 am Purchase | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL PARTNERS LP | 2,025,000 9.600% | 475,000 (+30.65%) | Filing History |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BLACKROCK INC BLK | 1,934,711 9.200% | -43,300 (-2.19%) | Filing History |
| 2024-01-22 12:25 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 425,640 2.020% | -1,086,552 (-71.85%) | Filing History |
| 2024-01-11 4:15 pm Purchase | 2024-01-05 | 13G | Enanta Pharmaceuticals, Inc. ENTA | MILLENNIUM MANAGEMENT L.L.C. | 1,314,949 6.200% | 290,273 (+28.33%) | Filing History |
| 2023-11-16 4:31 pm Purchase | 2023-11-07 | 13G | Enanta Pharmaceuticals, Inc. ENTA | MILLENNIUM MANAGEMENT L.L.C. | 1,024,676 4.900% | 1,024,676 (New Position) | Filing History |
| 2023-10-06 2:34 pm Sale | 2023-09-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BLACKROCK INC BLK | 1,978,011 9.400% | -1,775,064 (-47.30%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FIRST MANHATTAN CO | 243,718 1.170% | -865,118 (-78.02%) | Filing History |
| 2023-02-14 12:39 pm Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | ARMISTICE CAPITAL LLC | 2,078,000 9.990% | 1,022,000 (+96.78%) | Filing History |
| 2023-02-09 11:19 am Sale | 2022-12-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | VANGUARD GROUP INC | 1,522,189 7.320% | -103,720 (-6.38%) | Filing History |
| 2023-02-08 1:17 pm Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,512,192 7.270% | 385,123 (+34.17%) | Filing History |
| 2023-02-06 09:06 am Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL PARTNERS LP | 1,550,000 7.500% | 1,550,000 (New Position) | Filing History |